+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp



Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp



European Journal of Clinical Microbiology and Infectious Diseases 31(6): 941-946



Reference broth microdilution protocols for the antifungal susceptibility testing (AST) of yeasts are available, but routine AST relies more on simpler alternatives. In this work, the Etest and a novel flow cytometry (FC) method were compared to the Clinical Laboratory Standards Institute (CLSI) protocol M27-A3. Caspofungin and anidulafungin were tested against 60 clinical isolates of Candida glabrata, C. krusei, and C. parapsilosis. There were two intermediate susceptibility results and 19 out of 20 tested C. krusei strains were categorized as resistant to caspofungin (minimum inhibitory concentration [MIC] of 1.0 mg/L). There was a generally excellent essential agreement with the reference method, only interrupted by Etest results for the anidulafungin susceptibility of C. glabrata (80%) and the FC method's results for caspofungin with C. krusei (40%). Categorical agreements were excellent, with the notable exception of the caspofungin-resistant C. krusei, with 19 very major errors for the FC method and 19 minor errors plus one very major error for the Etest (5% and 0% categorical agreements, respectively). Two additional minor errors were registered for the FC method when testing C. parapsilosis with anidulafungin and caspofungin. Overall, these data come to question the suitability of recently approved clinical breakpoints in the case of C. krusei. Further studies including fks mutants are now required.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052244609

Download citation: RISBibTeXText

PMID: 21909651

DOI: 10.1007/s10096-011-1390-z


Related references

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. Journal of Clinical Microbiology 48(5): 1592-1599, 2010

Comparison of CLSI broth macrodilution and microdilution methods for echinocandin susceptibility testing of 5 Candida species. Diagnostic Microbiology and Infectious Disease 71(3): 320-322, 2011

Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. Journal of Clinical Microbiology 45(3): 796-802, 2007

Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp. Journal of Clinical Microbiology 49(5): 1765-1771, 2011

Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. Journal of Clinical Microbiology 45(11): 3522-3528, 2007

Comparison of CLSI broth macrodilution and microdilution methods for echinocandin susceptibility testing of 5Candidaspecies. 2011

Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients. Mycoses 40(7-8): 291-296, 1997

Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values. Journal of Clinical Microbiology 49(3): 845-850, 2011

Etest for susceptibility testing of Candida parapsilosis to caspofungin Comparison with NCCLS M27-A broth microdilution method. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 405, 2002

Comparison between E-test and CLSI broth microdilution method for antifungal susceptibility testing of Candida albicans oral isolates. Revista do Instituto de Medicina Tropical de Sao Paulo 50(1): 7-10, 2008

Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods. Journal of Clinical Microbiology 48(1): 154-161, 2010

Streptococcus pneumoniae susceptibility testing with clarithromycin Comparison of reference broth microdilution method to Etest. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 147, 1998

Comparison of Etest method to reference broth microdilution method for susceptibility testing of Yersinia pestis. 2007

Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis. Journal of Clinical Microbiology 49(5): 1956-1960, 2011

Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates. Journal of Antimicrobial ChemoTherapy 47(5): 521-526, 2001